search
Back to results

Mild Versus Moderate Therapeutic Hypothermia in Out-of-hospital Cardiac Arrest Patients (CAPITALCHILL)

Primary Purpose

Cardiac Arrest

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Therapeutic Hypothermia
Sponsored by
Ottawa Heart Institute Research Corporation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiac Arrest focused on measuring Therapeutic Hypothermia, Out of hospital cardiac arrest, Mild hypothermia, Moderate hypothermia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Out of hospital cardiac arrest patient
  2. Return of spontaneous circulation
  3. Glasgow Coma Score equal or lesser than 8.

Exclusion Criteria:

  1. Patients residing in a Nursing Home or patients unable to reside independently,
  2. Intracranial bleed responsible for the cardiac arrest,
  3. Severe coagulopathy with clinical evidence of major bleeding,
  4. Coma that is not attributable to cardiac arrest,
  5. Pregnancy,
  6. Life expectancy of < one year due to any cause unrelated to the cardiac arrest,
  7. Known coagulation disorder (i.e. INR >2.0, platelets <100,000 / mm3),
  8. Participation in a study with another investigational device or drug < four weeks,
  9. The Endovascular cooling (ZOLL) device is not available.

Sites / Locations

  • University of Ottawa Heart Institute

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Active Comparator

Arm Label

Moderate hypothermia

Mild Hypothermia

Arm Description

Therapeutic hypothermia at 31 degrees celsius

Therapeutic Hypothermia at 34 degrees Celsius

Outcomes

Primary Outcome Measures

Number of participants with death or poor neurologic outcome at 6 months
The primary outcome of the study will be death or poor neurologic outcome at six months. Neurologic outcome will be assessed by a specialist in rehabilitation medicine using the Disability Ratings Scale (DRS. Patients will be judged to have had a poor neurologic outcome if the score on the DRS scale is >5.

Secondary Outcome Measures

Number of mortality
All cause mortality will be recorded. Mortality will be adjudicated as cardiac versus non-cardiac.
Number of participants with stroke
Stroke will be classified as hemorrhagic versus non-hemorrhagic.
Number of participants with bleeding
Bleeding will be assessed using the TIMI definition and will be scored as major or minor.
Length of stay in the unit
Length of stay in the hospital
Number of participants with cardiogenic shock
Number of participants with repeat circulatory arrest requiring cardiopulmonary resuscitation (CPR)
Number of participants with seizures
Number of participants with renal failure requiring renal replacement therapy
Number of participants with ventilator associated pneumonia
Number of participants with stent thrombosis
Number of participants discharged home

Full Information

First Posted
November 8, 2013
Last Updated
February 8, 2021
Sponsor
Ottawa Heart Institute Research Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT02011568
Brief Title
Mild Versus Moderate Therapeutic Hypothermia in Out-of-hospital Cardiac Arrest Patients
Acronym
CAPITALCHILL
Official Title
Therapeutic Hypothermia Following Out-of-Hospital Cardiac Arrest - A Randomized Trial Comparing Mild and Moderate Therapeutic Hypothermia (CAPITAL CHILL)
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
August 2013 (undefined)
Primary Completion Date
March 2020 (Actual)
Study Completion Date
March 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ottawa Heart Institute Research Corporation

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This trial is currently a single-center, randomized, double-blind investigator initiated prospective clinical trial initiated at the University of Ottawa Heart Institute (UOHI). The plan is to expand the trial shortly as a multi-center project. The patients for this study will be recruited amongst comatose survivors of out-of-hospital cardiac arrest (OHCA). The aim of this study is to determine whether neurologic outcomes at six months are improved with moderate (31 degrees Celsius) versus mild (34 degrees Celsius) therapeutic hypothermia (TH) following return of spontaneous circulation (ROSC) in patients suffering OHCA, with ROSC defined as the resumption of sustained perfusing cardiac activity. The primary outcome will be the proportion of patients experiencing death or a poor neurologic outcome at six months after out of hospital cardiac arrest.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Arrest
Keywords
Therapeutic Hypothermia, Out of hospital cardiac arrest, Mild hypothermia, Moderate hypothermia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
360 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Moderate hypothermia
Arm Type
Other
Arm Description
Therapeutic hypothermia at 31 degrees celsius
Arm Title
Mild Hypothermia
Arm Type
Active Comparator
Arm Description
Therapeutic Hypothermia at 34 degrees Celsius
Intervention Type
Other
Intervention Name(s)
Therapeutic Hypothermia
Primary Outcome Measure Information:
Title
Number of participants with death or poor neurologic outcome at 6 months
Description
The primary outcome of the study will be death or poor neurologic outcome at six months. Neurologic outcome will be assessed by a specialist in rehabilitation medicine using the Disability Ratings Scale (DRS. Patients will be judged to have had a poor neurologic outcome if the score on the DRS scale is >5.
Time Frame
Six months
Secondary Outcome Measure Information:
Title
Number of mortality
Description
All cause mortality will be recorded. Mortality will be adjudicated as cardiac versus non-cardiac.
Time Frame
30 days and 6 months
Title
Number of participants with stroke
Description
Stroke will be classified as hemorrhagic versus non-hemorrhagic.
Time Frame
30 days and 6 months
Title
Number of participants with bleeding
Description
Bleeding will be assessed using the TIMI definition and will be scored as major or minor.
Time Frame
During index hospitalization
Title
Length of stay in the unit
Time Frame
Admission to unit to discharge from unit
Title
Length of stay in the hospital
Time Frame
Admission to hospital to discharge from hospital.
Title
Number of participants with cardiogenic shock
Time Frame
During index hospitalization
Title
Number of participants with repeat circulatory arrest requiring cardiopulmonary resuscitation (CPR)
Time Frame
Six months
Title
Number of participants with seizures
Time Frame
During index hospitalization
Title
Number of participants with renal failure requiring renal replacement therapy
Time Frame
During index hospitalization
Title
Number of participants with ventilator associated pneumonia
Time Frame
During index hospitalization
Title
Number of participants with stent thrombosis
Time Frame
Six months
Title
Number of participants discharged home
Time Frame
Six months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Out of hospital cardiac arrest patient Return of spontaneous circulation Glasgow Coma Score equal or lesser than 8. Exclusion Criteria: Patients residing in a Nursing Home or patients unable to reside independently, Intracranial bleed responsible for the cardiac arrest, Severe coagulopathy with clinical evidence of major bleeding, Coma that is not attributable to cardiac arrest, Pregnancy, Life expectancy of < one year due to any cause unrelated to the cardiac arrest, Known coagulation disorder (i.e. INR >2.0, platelets <100,000 / mm3), Participation in a study with another investigational device or drug < four weeks, The Endovascular cooling (ZOLL) device is not available.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michel R Le May, MD
Organizational Affiliation
Ottawa Heart Institute Research Corporation
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Ottawa Heart Institute
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
k1y 4w7
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
34665203
Citation
Le May M, Osborne C, Russo J, So D, Chong AY, Dick A, Froeschl M, Glover C, Hibbert B, Marquis JF, De Roock S, Labinaz M, Bernick J, Marshall S, Maze R, Wells G. Effect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes in Comatose Survivors of Out-of-Hospital Cardiac Arrest: The CAPITAL CHILL Randomized Clinical Trial. JAMA. 2021 Oct 19;326(15):1494-1503. doi: 10.1001/jama.2021.15703.
Results Reference
derived

Learn more about this trial

Mild Versus Moderate Therapeutic Hypothermia in Out-of-hospital Cardiac Arrest Patients

We'll reach out to this number within 24 hrs